Body composition as predictor of toxicity and outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (Nivo)
| Autor: | Itamar Shafran, Mor Moskovitz, Shlomit S. Shachar, Rachel Fried, Anat Reiner-Benaim, Gil Bar-Sela, Grant R. Williams, Mira Wollner |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Cancer medicine.disease 03 medical and health sciences Low muscle mass 030104 developmental biology 0302 clinical medicine Internal medicine Toxicity medicine In patient Non small cell Nivolumab business Lung cancer 030215 immunology |
| Zdroj: | Journal of Clinical Oncology. 36:e21010-e21010 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | e21010Background: Low muscle mass is associated with adverse cancer outcomes including increased chemotherapy toxicity and reduced survival, while adiposity is linked to chronic low grade inflammat... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|